247 related articles for article (PubMed ID: 9294848)
1. Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion.
Uckan D; Steele A; Cherry ; Wang BY; Chamizo W; Koutsonikolis A; Gilbert-Barness E; Good RA
Mol Hum Reprod; 1997 Aug; 3(8):655-62. PubMed ID: 9294848
[TBL] [Abstract][Full Text] [Related]
2. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus.
Kauma SW; Huff TF; Hayes N; Nilkaeo A
J Clin Endocrinol Metab; 1999 Jun; 84(6):2188-94. PubMed ID: 10372730
[TBL] [Abstract][Full Text] [Related]
3. Fas and Fas-ligand are expressed in the uteroplacental unit of first-trimester pregnancy.
Hammer A; Blaschitz A; Daxböck C; Walcher W; Dohr G
Am J Reprod Immunol; 1999 Jan; 41(1):41-51. PubMed ID: 10097786
[TBL] [Abstract][Full Text] [Related]
4. The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces.
Guller S; LaChapelle L
Semin Reprod Endocrinol; 1999; 17(1):39-44. PubMed ID: 10406074
[TBL] [Abstract][Full Text] [Related]
5. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells.
Bamberger AM; Schulte HM; Thuneke I; Erdmann I; Bamberger CM; ASA SL
J Clin Endocrinol Metab; 1997 Sep; 82(9):3173-5. PubMed ID: 9284765
[TBL] [Abstract][Full Text] [Related]
6. Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease.
Mor G; Gutierrez LS; Eliza M; Kahyaoglu F; Arici A
Am J Reprod Immunol; 1998 Aug; 40(2):89-94. PubMed ID: 9764350
[TBL] [Abstract][Full Text] [Related]
7. Labor-associated changes in Fas ligand expression and function in human placenta.
Balkundi DR; Hanna N; Hileb M; Dougherty J; Sharma S
Pediatr Res; 2000 Mar; 47(3):301-8. PubMed ID: 10709727
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis in the first trimester human placenta: the role in maintaining immune privilege at the maternal-foetal interface and in the trophoblast remodelling.
Jerzak M; Bischof P
Eur J Obstet Gynecol Reprod Biol; 2002 Jan; 100(2):138-42. PubMed ID: 11750952
[TBL] [Abstract][Full Text] [Related]
9. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis.
Abrahams VM; Straszewski-Chavez SL; Guller S; Mor G
Mol Hum Reprod; 2004 Jan; 10(1):55-63. PubMed ID: 14665707
[TBL] [Abstract][Full Text] [Related]
10. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy.
Pongcharoen S; Searle RF; Bulmer JN
Placenta; 2004 Apr; 25(4):321-30. PubMed ID: 15028424
[TBL] [Abstract][Full Text] [Related]
11. Regulation of FasL/Fas in human trophoblasts: possible implications for chorioamnionitis.
Balkundi DR; Ziegler JA; Watchko JF; Craven C; Trucco M
Biol Reprod; 2003 Aug; 69(2):718-24. PubMed ID: 12700199
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level.
Frängsmyr L; Baranov V; Nagaeva O; Stendahl U; Kjellberg L; Mincheva-Nilsson L
Mol Hum Reprod; 2005 Jan; 11(1):35-41. PubMed ID: 15579659
[TBL] [Abstract][Full Text] [Related]
13. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F
Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372
[TBL] [Abstract][Full Text] [Related]
14. Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system.
Kayisli UA; Selam B; Guzeloglu-Kayisli O; Demir R; Arici A
J Immunol; 2003 Sep; 171(5):2305-13. PubMed ID: 12928375
[TBL] [Abstract][Full Text] [Related]
15. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells.
Aschkenazi S; Straszewski S; Verwer KM; Foellmer H; Rutherford T; Mor G
Biol Reprod; 2002 Jun; 66(6):1853-61. PubMed ID: 12021072
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of Fas (APO-1, CD95)/Fas ligand by BeWo and NJG choriocarcinoma cell lines.
Rajashekhar G; Loganath A; Roy AC; Mongelli JM
Gynecol Oncol; 2003 Oct; 91(1):101-11. PubMed ID: 14529668
[TBL] [Abstract][Full Text] [Related]
18. Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege.
O'Connell J; Bennett MW; O'Sullivan GC; O'Callaghan J; Collins JK; Shanahan F
Clin Diagn Lab Immunol; 1999 Jul; 6(4):457-63. PubMed ID: 10391843
[TBL] [Abstract][Full Text] [Related]
19. Maternal-fetal tolerance is maintained despite transgene-driven trophoblast expression of MHC class I, and defects in Fas and its ligand.
Rogers AM; Boime I; Connolly J; Cook JR; Russell JH
Eur J Immunol; 1998 Nov; 28(11):3479-87. PubMed ID: 9842890
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of the expression of CD95 ligand transcript and protein in human placenta.
Zorzi W; Thellin O; Coumans B; Melot F; Hennen G; Lakaye B; Igout A; Heinen E
Placenta; 1998 May; 19(4):269-77. PubMed ID: 9639322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
